Search research articles
Contact Us
Filters
Showing results (231-240 of 239) with videos related to
Page
of 24
Sort By:
You have reached the last page of results.
This site can display upto 239 results.
Clinical Genetics
|
December 25, 2004
FMR1 alleles in Tasmania: a screening study of the special educational needs population
R J Mitchell, J J A Holden, C Zhang, et al.
Bioanalysis
|
May 11, 2017
A sensitive assay for ZYAN1 in human whole blood and urine utilizing positive LC-MS/MS electrospray ionization
Harilal Patel, Krunal Soni, Rucha Trivedi, et al.
Gut
|
December 1, 1993
Nature and standards of gastrointestinal and liver services in the United Kingdom
M J Farthing, R Williams, C H Swan, et al.
Health Technology Assessment (Winchester, England)
|
September 18, 2008
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial
A Grant, S Wileman, C Ramsay, et al.
Health Technology Assessment (Winchester, England)
|
June 8, 2013
Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
A M Grant, C Boachie, S C Cotton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2019
Most viral peptides displayed by class I MHC on infected cells are immunogenic
Nathan P Croft, Stewart A Smith, Jana Pickering, et al.
Journal of Clinical Gastroenterology
|
June 20, 2007
Whistler summary: "the slow rate of rapid progress"
Richard H Hunt, Guido H Tytgat, Peter Malfertheiner, et al.
Zoonoses and Public Health
|
September 25, 2019
Investigation and response to an outbreak of leptospirosis among raspberry workers in Australia, 2018
Anthea L Katelaris, Keira Glasgow, Kerryn Lawrence, et al.
Clinical Pharmacokinetics
|
May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Kevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Page
of 24
Search research articles
Search
Showing results (231-240 of 239) with videos related to
Sort By:
Page
of 24
You have reached the last page of results.
This site can display upto 239 results.
Clinical Genetics
|
December 25, 2004
FMR1 alleles in Tasmania: a screening study of the special educational needs population
R J Mitchell, J J A Holden, C Zhang, et al.
Bioanalysis
|
May 11, 2017
A sensitive assay for ZYAN1 in human whole blood and urine utilizing positive LC-MS/MS electrospray ionization
Harilal Patel, Krunal Soni, Rucha Trivedi, et al.
Gut
|
December 1, 1993
Nature and standards of gastrointestinal and liver services in the United Kingdom
M J Farthing, R Williams, C H Swan, et al.
Health Technology Assessment (Winchester, England)
|
September 18, 2008
The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial
A Grant, S Wileman, C Ramsay, et al.
Health Technology Assessment (Winchester, England)
|
June 8, 2013
Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)
A M Grant, C Boachie, S C Cotton, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 6, 2019
Most viral peptides displayed by class I MHC on infected cells are immunogenic
Nathan P Croft, Stewart A Smith, Jana Pickering, et al.
Journal of Clinical Gastroenterology
|
June 20, 2007
Whistler summary: "the slow rate of rapid progress"
Richard H Hunt, Guido H Tytgat, Peter Malfertheiner, et al.
Zoonoses and Public Health
|
September 25, 2019
Investigation and response to an outbreak of leptospirosis among raspberry workers in Australia, 2018
Anthea L Katelaris, Keira Glasgow, Kerryn Lawrence, et al.
Clinical Pharmacokinetics
|
May 17, 2017
Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers
Kevinkumar A Kansagra, Deven Parmar, Rajendra H Jani, et al.
Page
of 24